Heterotopic ossification in the setting of neuromuscular blockade

Arthritis and Rheumatism

Volumn 40, Issue 9, 1997, Pages 1619-1627

  Goodman, Thomas A ^a   Merkel, Peter A ^a   Perlmutter, Gary ^a   Doyle, Mittie Kelleher ^b   Krane, Stephen M ^a   Polisson, Richard P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; TUBOCURARINE CHLORIDE; VECURONIUM;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANESTHESIA COMPLICATION; ARTICLE; BONE SCINTISCANNING; BRAIN INJURY; BURN; CLINICAL ARTICLE; FEMALE; HETEROTOPIC OSSIFICATION; HUMAN; HUMAN TISSUE; MALE; NEUROMUSCULAR BLOCKING; PARALYSIS; PRIORITY JOURNAL; RISK FACTOR; SPINAL CORD INJURY;

ADULT; AGED; ALKALINE PHOSPHATASE; BONE AND BONES; CALCIUM; ELBOW; FEMALE; HIP JOINT; HUMANS; JOINT DISEASES; KNEE JOINT; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; OSSIFICATION, HETEROTOPIC; PULMONARY VENTILATION; RESPIRATORY DISTRESS SYNDROME, ADULT; SHOULDER JOINT; TECHNETIUM;

EID: 0030824212     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400911     Document Type: Article

References (35)

1. Cope R: Heterotopic ossification. South Med J 83:1058-1064, 1990
2. Garland DE: A clinical perspective on common forms of acquired heterotopic ossification. Clin Orthop 263:13-29, 1991
3. Jensen LL, Halar E, Little JW, Brooke MM: Neurogenic heterotopic ossification. Am J Phys Med 66:351-363, 1988
4. Clements NC, Camilli AE: Heterotopic ossification complicating critical illness. Chest 104:1526-1528, 1993
5. Goldberg MA, Schumacher HR: Heterotopic ossification mimicking acute arthritis after neurologic catastrophes. Arch Intern Med 137:619-621, 1977
6. Buschbacher R, Coplin B, Buschbacher L, McKinley W: Noninflammatory knee joint effusions in spinal cord-injured and other paralyzed patients. Am J Phys Med Rehabil 70:309-312, 1991
7. Orzel JA, Rudd TG: Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucleic Med 26:125-132, 1985
8. Furman R, Nicholas JJ, Jivoff L: Elevation of the serum alkaline phosphatase coincident with ectopic-bone formation in paraplegic patients. J Bone Joint Surg Am 52A:1131-1137, 1970
9. Kjaersgaard-Andersen P, Pedersen P, Kristensen SS, Schmidt SA, Pedersen NW: Serum alkaline phosphatase as an indicator of heterotopic bone formation following total hip arthroplasty. Clin Orthop 234:102-109, 1988
10. Finerman GAM, Stover SL: Heterotopic ossification following hip replacement or spinal cord injury: two clinical studies with EHDP. Metab Bone Dis Rel Res 3:337-342, 1981
11. Suzuki Y, Hisada K, Takeda M: Demonstration of myositis ossificans by 99mTc pyrophosphate bone scanning. Radiology 111:663-664, 1974
12. Tanaka T, Rossier AB, Hussey RW, Ahnberg DS, Treves S: Quantitative assessment of para-osteo-arthropathy and its maturation on serial radionuclide bone images. Radiology 123:217-221, 1977
13. Buring K: On the origin of cells in heterotopic bone formation. Clin Orthop 110:293-302, 1975
14. Sawyer JR, Myers MA, Rosier RN, Puzas JE: Heterotopic ossification: clinical and cellular aspects. Calcif Tissue Int 49:208-215, 1991
15. Ekelund A, Brosjo O, Nilsson OS: Experimental induction of heterotopic bone. Clin Orthop 263:102-112, 1991
16. Michelsson JK, Granroth G, Andersson LC: Myositis ossificans following forcible manipulation of the leg. J Bone and Joint Surg Am 62:811-815, 1980
17. Brailsford JF: The Radiology of Bones and Joints. London, 1948
18. Urist MR, DeLange RJ, Finerman GAM: Bone cell differentiation and growth factors. Science 220:680-686, 1983
19. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA: Identification of transforming growth factor b family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 87:9843-9847, 1990
20. Wang EA, Rosen V, D'Alessandro JS: Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 87:2220-2224, 1990
21. Ripamonti U, Reddi AH: Growth and morphogenetic factors in bone induction: role of osteogenin and related bone morphogenetic proteins in craniofacial and periodontal bone repair. Crit Rev Oral Biol Med 3:1-14, 1992
22. Katagiri T, Yamaguchi A, Komaki M: Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766, 1994
23. Rosen V, Nove J, Song JJ: Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res 9:1759-1761, 1994
24. Erlebacher A, Filvaroff EH, Gitelman SE: Toward a molecular understanding of skeletal development. Cell 80:371-378, 1995
25. Garland DE, Orwin JF: Resection of heterotopic ossification in patients with spinal cord injuries. Clin Orthop 242:169-176, 1989
26. Stover SL, Niemann KM, Tulloss JR: Experience with surgical resection of heterotopic bone in spinal cord injury patients. Clin Orthop 263:71-77, 1991
27. Seegenschmiedt MH, Goldmann AR, Martus P: Prophylactic radiation therapy for prevention of heterotopic ossification after total hip arthroplasty: results in 141 high-risk hips. Radiology 188:257-264, 1993
28. DeFlitch CJ, Stryker JA: Postoperative hip irradiation in prevention of heterotopic ossification: causes of treatment failure. Radiology 188:265-270, 1993
29. Maloney WJ, Jasty M, Willett C: Prophylaxis for heterotopic bone formation after total hip arthroplasty using low-dose radiation in high-risk patients. Clin Orthop 280:230-234, 1990
30. Garland DE, Alday B, Venos KG: Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. Clin Orthop 176:197-200, 1983
31. Spielman G, Gennarelli TA, Rogers CR: Disodium ctidronate: its role in preventing heterotopic ossification in severe head injury. Arch Phys Med Rehabil 64:539-542, 1983
32. Stover SE, Niemann KM, Miller JM: Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients. J Bone Joint Surg Am 58A:683-688, 1976
33. Lindholm TS, Bauer FCH, Rindell KAJ: High doses of the diphosphonate EHDP for the prevention of heterotopic ossification. Scand J Rheumatol 16:33-39, 1987
34. Kjaersgaard-Andersen P, Schmidt SA: Total hip arthroplasty: the role of antiinflammatory medications in the prevention of heterotopic ossification. Clin Orthop 263:78-87, 1991
35. Buschbacher R, McKinley W, Buschbacher E, Devaney CN, Coplin B: Warfarin in prevention of heterotopic ossification. Am J Phys Med Rehabil 71:86-91, 1992